May 08, 2025 | UC Irvine Joe C. Wen School of Population & Public Health

---

Member, Denise Payán, MPP, PhD, receives Fulbright scholar award

Research will examine nutrition policy design and implementation in Australia

May 07, 2025 | OncLive

---

Member, Nataliya Mar, MD - video highlights concerning ARPI therapy

Discusses the challenges associated with androgen receptor pathway inhibitor

May 06, 2025 | UC Irvine Joe C. Wen School of Population & Public Health

---

Member, Matthew Landry, PhD, RDN, named 2025 UCDC Presidential Faculty Fellow

Research focus: How clinical trials can best evaluate the impacts of plant-forward/based dietary patterns.

May 01, 2025 | BioSpace

---

Richard Van Etten, MD, PhD, presented the CLiMB study

2025 Digestive Disease Week in San Diego, May 6, 2025

Apr 30, 2025 | UCI School of Medicine

---

Congratulations to members Drs. Semler, Rezazadeh Kalebasty, Sadigh, and Flanagan

The School of Medicine Office of Academic Affairs annually recognizes excellence and innovation in mentoring at UCI School of Medicine, specifically in the domain of faculty mentoring other faculty.

Apr 29, 2025 | UC Irvine Digest

---

Blending Science and Art

“The goal of this inaugural workshop is to teach healing through dance and highlight non-classical, non-scientific ways of looking at medicine,” says Dr. Frank L. Meyskens, founding director emeritus of the UCI Health Chao Family Comprehensive Cancer Center.

Apr 24, 2025 | University of California Health

---

University of California Lung Cancer Consortium and AstraZeneca

Announced a five-year partnership to expand the Healthy Lungs California initiative

Apr 23, 2025 | UC Irvine News

---

Member, Robert Spitale, PhD, quoted

Disease-fighting proteins in the brain can potentially revolutionize treatments for Alzheimer’s and other neurological disorders

Apr 23, 2025 | Healio

---

Farshid Dayyani, MD, PhD - early phase enrollment

Time to rethink when patients with cancer enroll

Apr 21, 2025 | UCI School of Medicine

---

New findings reveal why only some cancers respond to ATR inhibitor therapy

Rémi Buisson, PhD, and his team are uncovering why some cancers respond well to ATR inhibitors while others resist, aiming to improve personalized treatment through key biomarker discovery.